Green Cross (005250) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Green Cross (005250) has a cash flow conversion efficiency ratio of 0.074x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩139.95 Billion ≈ $94.84 Million USD) by net assets (₩1.89 Trillion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 005250 net asset quality score to measure how much of total assets are equity-financed.
Green Cross - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Green Cross's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Green Cross (005250) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Green Cross Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Green Cross ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vátryggingafélag Íslands hf
IC:SKAGI
|
0.083x |
|
ABEONA THERAPEUT. DL-01
F:PCJ
|
-0.113x |
|
Guangdong Tianhe Agricultural Means
SHE:002999
|
-0.233x |
|
NACCO Industries Inc
NYSE:NC
|
0.028x |
|
Phihong Technology Co Ltd
TW:2457
|
-0.063x |
|
Beijing Dalong Weiye Real Estate Development Co Ltd
SHG:600159
|
-0.027x |
|
Fujian Cement Inc
SHG:600802
|
-0.135x |
|
HL Corp Shenzhen
SHE:002105
|
0.054x |
Annual Cash Flow Conversion Efficiency for Green Cross (2000–2024)
The table below shows the annual cash flow conversion efficiency of Green Cross from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see 005250 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩1.85 Trillion ≈ $1.26 Billion |
₩-89.95 Billion ≈ $-60.96 Million |
-0.049x | -130.42% |
| 2023-12-31 | ₩1.88 Trillion ≈ $1.28 Billion |
₩-39.65 Billion ≈ $-26.87 Million |
-0.021x | -142.67% |
| 2022-12-31 | ₩1.97 Trillion ≈ $1.33 Billion |
₩97.16 Billion ≈ $65.84 Million |
0.049x | -9.05% |
| 2021-12-31 | ₩1.91 Trillion ≈ $1.29 Billion |
₩103.77 Billion ≈ $70.32 Million |
0.054x | +154.07% |
| 2020-12-31 | ₩1.67 Trillion ≈ $1.13 Billion |
₩35.77 Billion ≈ $24.24 Million |
0.021x | +320.95% |
| 2019-12-31 | ₩1.51 Trillion ≈ $1.02 Billion |
₩7.65 Billion ≈ $5.18 Million |
0.005x | -80.40% |
| 2018-12-31 | ₩1.45 Trillion ≈ $984.76 Million |
₩37.64 Billion ≈ $25.51 Million |
0.026x | -74.19% |
| 2017-12-31 | ₩1.44 Trillion ≈ $975.64 Million |
₩144.48 Billion ≈ $97.91 Million |
0.100x | +17256.99% |
| 2016-12-31 | ₩1.38 Trillion ≈ $933.18 Million |
₩-805.47 Million ≈ $-545.86K |
-0.001x | -110.87% |
| 2015-12-31 | ₩1.31 Trillion ≈ $885.99 Million |
₩7.04 Billion ≈ $4.77 Million |
0.005x | -88.35% |
| 2014-12-31 | ₩1.18 Trillion ≈ $800.39 Million |
₩54.54 Billion ≈ $36.96 Million |
0.046x | +189.06% |
| 2013-12-31 | ₩1.10 Trillion ≈ $745.23 Million |
₩17.57 Billion ≈ $11.91 Million |
0.016x | -57.76% |
| 2012-12-31 | ₩972.83 Billion ≈ $659.27 Million |
₩36.80 Billion ≈ $24.94 Million |
0.038x | -70.84% |
| 2011-12-31 | ₩895.76 Billion ≈ $607.04 Million |
₩116.18 Billion ≈ $78.73 Million |
0.130x | -69.37% |
| 2010-12-31 | ₩839.83 Billion ≈ $569.14 Million |
₩355.62 Billion ≈ $241.00 Million |
0.423x | -54.13% |
| 2009-12-31 | ₩522.78 Billion ≈ $354.28 Million |
₩482.60 Billion ≈ $327.05 Million |
0.923x | +93.20% |
| 2008-12-31 | ₩350.47 Billion ≈ $237.51 Million |
₩167.47 Billion ≈ $113.49 Million |
0.478x | -36.16% |
| 2007-12-31 | ₩351.08 Billion ≈ $237.92 Million |
₩262.77 Billion ≈ $178.07 Million |
0.748x | +59.53% |
| 2006-12-31 | ₩221.73 Billion ≈ $150.26 Million |
₩104.03 Billion ≈ $70.50 Million |
0.469x | +78.48% |
| 2005-12-31 | ₩236.96 Billion ≈ $160.59 Million |
₩62.29 Billion ≈ $42.22 Million |
0.263x | -69.80% |
| 2003-12-31 | ₩210.22 Billion ≈ $142.46 Million |
₩182.96 Billion ≈ $123.99 Million |
0.870x | +648.32% |
| 2001-12-31 | ₩273.93 Billion ≈ $185.64 Million |
₩31.86 Billion ≈ $21.59 Million |
0.116x | -39.13% |
| 2000-12-31 | ₩282.15 Billion ≈ $191.21 Million |
₩53.91 Billion ≈ $36.53 Million |
0.191x | -- |
About Green Cross
Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pert… Read more